CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Research and Treatment. 2006;38(1):35-39.   Published online 2006 February 28    DOI: https://doi.org/10.4143/crt.2006.38.1.35

Excel Download

Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer
Cancer Research and Treatment. 2006;38(1):35   Crossref logo
Link1 Link2

HER2-positive metastatic breast cancer: second-line treatment
Handbook of HER2-Targeted Agents in Breast Cancer. 2016;71-86   Crossref logo
Link1

HER2-positive metastatic breast cancer: first-line treatment
Handbook of HER2-Targeted Agents in Breast Cancer. 2016;51-69   Crossref logo
Link1

Emerging targeted agents for HER2-positive breast cancer
Handbook of HER2-Targeted Agents in Breast Cancer. 2016;87-110   Crossref logo
Link1

HER2-positive breast cancer: neoadjuvant and adjuvant therapy
Handbook of HER2-Targeted Agents in Breast Cancer. 2016;29-49   Crossref logo
Link1

1–33 Predicting Tissue HER2 Status Using Serum HER2 Levels in Patients with Metastatic Breast Cancer
Breast Diseases: A Year Book Quarterly. 2007;18(1):63-64   Crossref logo
Link1 Link2

HER2-Positive Breast Cancer
Her2-Positive Breast Cancer. 2019;63-74   Crossref logo
Link1 Link2

Biosimilars for HER2-Positive Breast Cancer
Her2-Positive Breast Cancer. 2019;231-237   Crossref logo
Link1 Link2

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy
Cancer. 2011;117(21):5013-5020   Crossref logo
Link1 Link2

PO141 SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS
The Breast. 2015;24:S70   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.